DK2238458T3 - Fremgangsmåde til forudsigelse af responsivitet på en farmaceutisk terapi for obesitet - Google Patents

Fremgangsmåde til forudsigelse af responsivitet på en farmaceutisk terapi for obesitet

Info

Publication number
DK2238458T3
DK2238458T3 DK08867898.2T DK08867898T DK2238458T3 DK 2238458 T3 DK2238458 T3 DK 2238458T3 DK 08867898 T DK08867898 T DK 08867898T DK 2238458 T3 DK2238458 T3 DK 2238458T3
Authority
DK
Denmark
Prior art keywords
obesity
pharmaceutical agent
predicting responsiveness
pharmaceutical therapy
biomarker
Prior art date
Application number
DK08867898.2T
Other languages
English (en)
Inventor
Jennifer K Leohr
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40386209&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2238458(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of DK2238458T3 publication Critical patent/DK2238458T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/044—Hyperlipemia or hypolipemia, e.g. dyslipidaemia, obesity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Child & Adolescent Psychology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK08867898.2T 2007-12-19 2008-12-18 Fremgangsmåde til forudsigelse af responsivitet på en farmaceutisk terapi for obesitet DK2238458T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1488107P 2007-12-19 2007-12-19
PCT/US2008/087367 WO2009085917A1 (en) 2007-12-19 2008-12-18 Method for predicting responsiveness to a pharmaceutical therapy for obesity

Publications (1)

Publication Number Publication Date
DK2238458T3 true DK2238458T3 (da) 2012-01-23

Family

ID=40386209

Family Applications (1)

Application Number Title Priority Date Filing Date
DK08867898.2T DK2238458T3 (da) 2007-12-19 2008-12-18 Fremgangsmåde til forudsigelse af responsivitet på en farmaceutisk terapi for obesitet

Country Status (17)

Country Link
US (2) US8084261B2 (da)
EP (2) EP2235544A1 (da)
JP (1) JP5242701B2 (da)
KR (2) KR20100088624A (da)
AT (1) ATE530916T1 (da)
AU (2) AU2008343177B2 (da)
BR (2) BRPI0821364A2 (da)
CA (2) CA2710248A1 (da)
CY (1) CY1112352T1 (da)
DK (1) DK2238458T3 (da)
ES (1) ES2373625T3 (da)
HR (1) HRP20110840T1 (da)
MX (1) MX2010006890A (da)
PL (1) PL2238458T3 (da)
PT (1) PT2238458E (da)
SI (1) SI2238458T1 (da)
WO (2) WO2009085917A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2517268T3 (es) * 2009-07-22 2014-11-03 Eli Lilly And Company Procedimiento para predecir el aumento de peso asociado a una terapia farmacéutica
WO2014204990A2 (en) * 2013-06-18 2014-12-24 The George Washington University, A Congressionally Chartered Not-For-Profit Corporation Methods of predicting of chemical properties from spectroscopic data
WO2016065463A1 (en) * 2014-10-28 2016-05-06 2352409 Ontario Inc. Methods for providing personalized diet and activity recommendations that adapt to the metabolism of each dieter individually using frequent measurements of activity and triglyceride levels
KR102397234B1 (ko) 2020-09-17 2022-05-12 가천대학교 산학협력산 약물 순응도 평가 방법 및 시스템

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993003450A1 (en) * 1991-07-30 1993-02-18 North Carolina State University Method and apparatus for measuring blood lipoprotein levels by nmr spectroscopy
FR2767135B1 (fr) * 1997-08-06 2002-07-12 Genset Sa Recepteur complexe lsr, activite, clonage, et application au diagnostic, a la prevention et/ou au traitement de d'obesite et des risques ou complications associes
AU2054000A (en) * 1999-02-26 2000-09-14 Lipomed, Inc. Methods, systems, and computer program products for analyzing and presenting risk assessment results based on nmr lipoprotein analysis of blood
WO2003012416A1 (en) * 2001-08-01 2003-02-13 Liposcience, Inc. Method of determining presence and concentration of lipoprotein x in blood plasma and serum
CA2477614A1 (en) * 2002-03-05 2003-09-18 Merck & Co., Inc. Biomarker for efficacy of appetite suppressant drugs
CA2561536C (en) 2004-04-01 2017-09-19 Liposcience, Inc. Nmr clinical analyzers and related methods, systems, modules and computer program products for clinical evaluation of biosamples
WO2006098394A1 (ja) * 2005-03-14 2006-09-21 Japan Tobacco Inc. 脂質吸収抑制方法および脂質吸収抑制剤
EP1876448A1 (en) * 2005-09-30 2008-01-09 DIGILAB BioVisioN GmbH Method and analytical reagents for identifying therapeutics using biomarkers responsive to thiazolidinediones.

Also Published As

Publication number Publication date
KR101240875B1 (ko) 2013-03-08
US8084261B2 (en) 2011-12-27
CA2710248A1 (en) 2009-07-09
JP5242701B2 (ja) 2013-07-24
PL2238458T3 (pl) 2012-03-30
US20100268474A1 (en) 2010-10-21
WO2009085917A1 (en) 2009-07-09
KR20100084577A (ko) 2010-07-26
AU2008343177A1 (en) 2009-07-09
EP2238458A1 (en) 2010-10-13
ATE530916T1 (de) 2011-11-15
US8355877B2 (en) 2013-01-15
CA2710395C (en) 2016-10-18
AU2008343177B2 (en) 2013-09-26
US20100248375A1 (en) 2010-09-30
EP2238458B1 (en) 2011-10-26
EP2235544A1 (en) 2010-10-06
MX2010006890A (es) 2010-09-30
ES2373625T3 (es) 2012-02-07
PT2238458E (pt) 2012-01-11
CA2710395A1 (en) 2009-07-09
JP2011508218A (ja) 2011-03-10
HRP20110840T1 (hr) 2011-12-31
BRPI0821364A2 (pt) 2015-06-16
SI2238458T1 (sl) 2012-02-29
WO2009085927A1 (en) 2009-07-09
CY1112352T1 (el) 2015-12-09
BRPI0821051A2 (pt) 2015-06-16
BRPI0821051B1 (pt) 2022-02-08
AU2008343187A1 (en) 2009-07-09
KR20100088624A (ko) 2010-08-09

Similar Documents

Publication Publication Date Title
FI20075062A0 (fi) Menetelmä, laite, järjestelmä, tietokoneohjelmatuote ja tietokoneohjelman jakeluväline
EP2203112A4 (en) METHOD, SYSTEM AND COMPUTER SIMULATION ENVIRONMENT FOR VERIFICATION OF MONITORING AND CONTROL STRATEGIES AT DIABETES
DE602006010637D1 (de) Steuermethode für Virtualisation der Vorrichtung in Speichersystem.
EP2219130A4 (en) METHOD AND APPARATUS FOR DETECTING THE MALICIOUS BEHAVIOR OF A COMPUTER PROGRAM
EP2587473A4 (en) ACTIVE MATRIX SUBSTRATE, DISPLAY DEVICE AND METHOD FOR TESTING THE ACTIVE MATRIX SUBSTRATE OR DISPLAY DEVICE
WO2012078806A3 (en) Non-gaming on-line achievement awards
BR112014002109A2 (pt) sensor de fibra ótica e método para aderir uma fibra ótica a um substrato
FI20060223A (fi) Menetelmä, järjestelmä ja tietokoneohjelmatuote mittauslaitteen paikantamiseksi ja suurten kappaleiden mittaamiseksi
BRPI0913271A2 (pt) sistemas de infusão incluindo manutenção e/ou operação facilitadas por computador e método de uso
PH12015500545A1 (en) Methods for modulating corticosterone levels in psychologically stressed individuals
FR2926375B1 (fr) Procede d'execution d'une application informatique, kit et aeronef associes
EP2357562A4 (en) SYSTEM FOR ASSESSING ACTIONS IN RESPECT OF EVENTS DETECTED, METHOD FOR ASSISTING THE EXECUTION OF ACTIONS IN REACTION TO DETECTED EVENTS, AID DEVICE AND COMPUTER PROGRAM
BRPI0916174A2 (pt) "sistema de exibição, método e produto de programa de computador"
BRPI0917616A2 (pt) arranjo para medir a velocidade local de um líquido que contém um material magnético em uma veia dentro de uma região de ação, método para medir a velocidade local de um líquido que contém um material magnético em uma veia dentro de uma região de ação e programa de computador
GB2509647A (en) Testing transaction applications
DK2040807T3 (da) Fremgangsmåde, system og måleindretning til måling af atletisk arbejde udført med vægtstakenhed samt vægtstakenhed
DK2238458T3 (da) Fremgangsmåde til forudsigelse af responsivitet på en farmaceutisk terapi for obesitet
BRPI0814119A2 (pt) Método de análise de diafragma e uso dos produtos obtidos de acordo com o método
EP2109824A4 (en) PERIPHERAL COMPUTER DEVICE IMPLEMENTED AS OPTICAL STORAGE DEVICE AND / OR SOFTWARE DEPOSITED DISK AND METHOD FOR IMPLEMENTING SAME
GB201016616D0 (en) Method and system for determining characteristics of an embryo and uses thereof
MX337767B (es) Tecnologia de simulacion integrada.
IN2013CN00326A (da)
FI20115411L (fi) Laitoksen mittausohjauslaite ja -menetelmä
FR2931613B1 (fr) Dispositif et procede de verification d'integrite d'objets physiques
DK2560059T3 (da) Computeranordning og fremgangsmåder til at præsentere data og identificere fejl i forsyningsnet